BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Antonio Chiappa, Andrew P Zbar, Michael Innis, Stuart Garriques, Emilio Bertani, Roberto Biffi, Giancarlo Pruneri, Felipe Luzzato, Paolo Della Vigna, Cristina Trovato, Bruno Andreoni. Prognostic factors affecting survival after surgical resection of gastrointestinal stromal tumours: a two-unit experience over 10 yearsWorld Journal of Surgical Oncology 2006; 4(1) doi: 10.1186/1477-7819-4-73
2
R. S. Meara, J. Cangiarella, A. Simsir, D. Horton, I. Eltoum, D. C. Chhieng. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53Cytopathology 2007; 18(5): 283 doi: 10.1111/j.1365-2303.2007.00505.x
3
Jason S. Gold, Sanne M. van der Zwan, Mithat Gönen, Robert G. Maki, Samuel Singer, Murray F. Brennan, Cristina R. Antonescu, Ronald P. DeMatteo. Outcome of Metastatic GIST in the Era before Tyrosine Kinase InhibitorsAnnals of Surgical Oncology 2007; 14(1): 134 doi: 10.1245/s10434-006-9177-7
4
Christopher L. Corless, Christine M. Barnett, Michael C. Heinrich. Gastrointestinal stromal tumours: origin and molecular oncologyNature Reviews Cancer 2011; 11(12): 865 doi: 10.1038/nrc3143
5
Chun-Meng Wang, Kai Huang, Ye Zhou, Chun-Yan Du, Yan-Wei Ye, Hong Fu, Xiao-Yan Zhou, Ying-Qiang Shi. Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumorsJournal of Cancer Research and Clinical Oncology 2010; 136(7): 1065 doi: 10.1007/s00432-009-0753-7
6
Christopher L. Corless, Michael C. Heinrich. Molecular Pathobiology of Gastrointestinal Stromal SarcomasAnnual Review of Pathology: Mechanisms of Disease 2008; 3(1): 557 doi: 10.1146/annurev.pathmechdis.3.121806.151538
7
R. L. Jones. Practical Aspects of Risk Assessment in Gastrointestinal Stromal TumorsJournal of Gastrointestinal Cancer 2014; 45(3): 262 doi: 10.1007/s12029-014-9615-x
8
Ronald P. DeMatteo, Jason S. Gold, Lisa Saran, Mithat Gönen, Kui Hin Liau, Robert G. Maki, Samuel Singer, Peter Besmer, Murray F. Brennan, Cristina R. Antonescu. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)Cancer 2008; 112(3): 608 doi: 10.1002/cncr.23199
9
Christopher L Corless. Gastrointestinal stromal tumors: what do we know now?Modern Pathology 2014; 27(S1): S1 doi: 10.1038/modpathol.2013.173
10
Jennifer M. Racz, Savtaj S. Brar, Michelle C. Cleghorn, M. Carolina Jimenez, Arash Azin, Eshetu G. Atenafu, Timothy D. Jackson, Allan Okrainec, Fayez A. Quereshy. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumorsJournal of Surgical Oncology 2015; 111(4): 371 doi: 10.1002/jso.23839
11
Meera Hameed, Christopher Corless, Suzanne George, Jason L. Hornick, Sanjay Kakar, Alexander J. Lazar, Laura Tang. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Gastrointestinal Stromal TumorsArchives of Pathology & Laboratory Medicine 2015; 139(10): 1271 doi: 10.5858/arpa.2014-0578-CP
12
Jason S Gold, Mithat Gönen, Antonio Gutiérrez, Javier Martín Broto, Xavier García-del-Muro, Thomas C Smyrk, Robert G Maki, Samuel Singer, Murray F Brennan, Cristina R Antonescu, John H Donohue, Ronald P DeMatteo. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysisThe Lancet Oncology 2009; 10(11): 1045 doi: 10.1016/S1470-2045(09)70242-6
13
Patrick Schöffski, Jean-Yves Blay, Isabelle Ray-Coquard. Cabozantinib as an emerging treatment for sarcomaCurrent Opinion in Oncology 2020; 32(4): 321 doi: 10.1097/CCO.0000000000000644